IL-6 causes bone resorption and cartilage degeneration by inducing the production of MMPs and NF-B ligand (RANKL) receptors (75, 76)
Safer / Established Alternatives for Recovery Alternatives to BPC-157 peptide for injury recovery include several mainstream, evidence-based therapies with well-established safety profiles: Physical Therapy (PT): Targeted exercise and rehab, proven for joint/tendon rehabilitation NSAIDs and medical management: Used for acute inflammation or pain, under physician guidance Platelet-Rich Plasma (PRP) injections: Increasing data support their use in certain soft-tissue injuries Surgery, where indicated, should only be performed under the care of a licensed surgeon None of these options carries the gray-market risk or purity uncertainty of peptides
Our team spends a significant amount of time helping patients understand this landscape because it's rarely straightforward
The main ones you'll hear about: Wegovy (semaglutide) - once weekly injection Saxenda (liraglutide) - daily injection Zepbound (tirzepatide) - once weekly injection (NOT yet approved for kids under 18) Two major studies found that liraglutide and semaglutide help adolescents lose 5-16% percent of their body fat, improve blood sugar control and get healthier overall
Where GLP-1s Fit in the Menopausal Framework Returning to the framework established in the previous section, the menopausal transition represents a disruption operating on two levels: the upstream withdrawal of hormonal signaling, and the downstream metabolic consequences that withdrawal produces